HFD is known to trigger β-cell mass expansion through enhanced β-cell proliferation, a response that can either precede or follow the onset of insulin resistance (Weir & Bonner-Weir 2004), resulting in a compensatory increase in insulin secretion to correct hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.